Parliament Workbench
Data: Official Report to 19 Nov 2026

Official Report · Committee

Continued Petitions

Whole Plant Cannabis Oil (PE1884)

Wednesday 23 March 2022 Citizen Participation and Public Petitions Committee About 11:15 Petitions 5 contributions · 3 speakers

Speakers

Choose an MSP to read only their contributions

The record

5 contributions
Jackson Carlaw Con The Convener · Eastwood
link

PE1884, which was lodged by Steve Gillan, calls on the Scottish Parliament to urge the Scottish Government to make whole plant cannabis oil available on the national health service, or to provide funds for private access for severely epileptic children and adults where all other NHS epileptic drugs have failed to help.

When we last considered the petition, we agreed to write to the Cabinet Secretary for Health and Social Care to seek information about the progress of clinical trials and further information on his discussions with the UK Government. The cabinet secretary’s response stated that he thinks that

“the lack of evidence on the quality, safety and efficacy”

of cannabis-based products for medicinal uses is “the main barrier” to them being prescribed by NHS clinicians, and he stressed the importance of development of the trials. He outlined plans to undertake two randomised and controlled trials of their use in early-onset epilepsy. The trials will compare medicines that contain only cannabidiol with ones that contain CBD and tetrahydrocannabinol and with placebos. That is to help answer the question of whether adding THC to CBD improves anti-epileptic properties. He also indicated that commercial discussions about the supply of products to the trial are under way, and that further details of the trials, including the timetable, will be dependent on the conclusion of those discussions.

The cabinet secretary stated that a meeting was scheduled for early February with the UK Minister for Patient Safety and Primary Care, Maria Caulfield MP. It was to include a consideration of ways in which the trials can be expedited.

The committee also requested information on existing evidence from other countries from the Scottish Parliament information centre. Its review is included in your papers pack at annex D. It provides information on current guidelines from Australia, America, Ireland and Canada. It highlights that a review on medicinal cannabis in Australia was examined by the UK Government. The UK Government stated that the review showed

“limited but high quality evidence for the use of medicinal cannabis products”

to treat epilepsy.

The use and efficacy of THC treatments is addressed in the guidance from Australia, Ireland and Canada. It indicates that the evidence base for THC is complex in that it may have either pro or anti-epileptic properties.

Much of the guidance in other jurisdictions acknowledges that limited evidence is available for the use of cannabis-based products for medicinal use and frequently advises that such products should be prescribed as an add-on treatment with existing anti-epileptic drugs.

The petitioner points to three existing prescriptions across the UK, and reiterates that he does not accept that there is a lack of evidence for prescribing. He explains that the prescriptions have been in place for three years, and he considers that to be an example of “reliable evidence” for its use by the NHS.

Again, that was quite a long introduction. Do colleagues have any comments that they wish to add?

11:15

David Torrance SNP Kirkcaldy
link

In light of the meeting with Minister for Patient Safety and Primary Care, Maria Caulfield, having been held in February, could we write to the cabinet secretary to ask him for an update on how that went? Can we also ask when commercial discussions about the supply of the products to trials are likely to conclude; whether the trials will include patients, including children, with severe epileptic conditions and whether patients in Scotland will be recruited for the trials? Can we also ask for further information on the timescales for trials and how they can be expedited, and, depending on the outcome of the trials, the timescales for achieving authorisation?

Jackson Carlaw Con The Convener · Eastwood
link

Thank you. Again, that is quite a comprehensive series of recommendations. Would anybody like to add to that, or is the committee content to support that?

Paul Sweeney Lab Glasgow
link

I think that it is also important to raise the fact that people are self-medicating with THCs already, where they have got a supply from unofficial sources. It might be worth engaging with the Minister for Drugs Policy, Angela Constance, about the pattern of illicit access to substances that are cannabis-derived products.

That might also illustrate that, where health and social care partnerships have introduced programmes such as herb-assisted treatment, it is actually seen as a public health benefit that people are medicating themselves in that way, as it is much more satisfactory that people do that in a controlled environment. Perhaps there is an angle that is not simply about the context of prescribing by a general practitioner or a clinician but about instances in which people are already self-medicating, and recognising that there is a public health interest in ensuring that harms are reduced in that situation.

Jackson Carlaw Con The Convener · Eastwood
link

Are members content to add those recommendations to our actions?

Members indicated agreement.

  1. 09:30 Continued Petitions Petitions · 54
  2. 10:15 Continued Petitions Petitions · 40
  3. 10:45 Continued Petitions Petitions · 3
  4. 11:15 Continued Petitions Petitions · 5
  5. 11:15 Continued Petitions Petitions · 3
  6. 11:15 Continued Petitions Petitions · 3
  7. 11:15 Continued Petitions Petitions · 9
  8. 11:15 Continued Petitions Petitions · 10
  9. 11:15 Continued Petitions Petitions · 3
  10. 11:15 New Petitions Petitions · 9
  11. 11:15 New Petitions Petitions · 7

The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.